Quantcast

Latest Biomarkers Stories

2014-09-18 08:29:25

Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept. 18, 2014 /PRNewswire/ -- Australian biomarker discovery company Minomic International Ltd will today launch an important US trial of its MiStat(TM) prostate cancer screening test, planning to achieve US Food and Drug Administration (FDA) regulatory approval upon completion. Minomic's proprietary MiStat(TM) technology is a screening assay capable of identifying the presence of a...

2014-09-17 08:30:32

Proprietary genomic-based VPAC1 cancer biomarker to be co-developed worldwide? PARK CITY, Utah, Sept. 17, 2014 /PRNewswire/ -- NuView Life Sciences, Inc. (NuView) announced entry into an exclusive global licensing and collaboration agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) to further develop and commercialize NuView's investigative genomic-based diagnostic biomarker to detect cancers of the breast and prostate. The agreement also includes all other future...

2014-09-16 12:31:31

SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY). Denovo gains all rights to develop, manufacture and commercialize enzastaurin globally, including transfer of all intellectual property and other rights, data, and information. http://photos.prnewswire.com/prnvar/20140820/138306 Lilly developed enzastaurin in a variety of indications, including in...

2014-09-08 08:31:48

NephroCheck® Test System Receives FDA Clearance In United States For Risk Assessment Of Acute Kidney Injury SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- A novel test used to assess risk for acute kidney injury (AKI) could help physicians significantly improve management of intensive care unit (ICU) patients at risk for AKI, who annually account for 5 million admissions.[1] Inadequacies in assessment and management of AKI have been cited as contributing to an increased number of deaths...

2014-09-01 23:01:01

New research study “Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014” worked out by Biopharm Reports is now available at MarketPublishers.com. London, UK (PRWEB) September 01, 2014 Currently, scientists continue to face fundamental challenges in developing more effective treatments for Alzheimer's disease (AD), which reflects their poor understanding of the disease....

2014-09-01 12:23:53

DUBLIN, Sept. 1, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the " Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of new developments relating to early-stage minimally-invasive biomarkers in Alzheimer's disease, which...

2014-08-27 23:08:41

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC) for prostate cancer therapy. Under the agreement, Catalent will initially produce the antibody for a clinical study with a view to larger scale production subject...

2014-08-26 12:26:17

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biomarkers: Technologies and Global Marketshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/biomarkers/biomarkers_technologies_global_markets.htmlREPORT HIGHLIGHTSThe global biomarkers market is expected to grow from $29.3 billion in 2013 to $53.6 billion in 2018, a compound annual growth rate (CAGR) of 12.8%.This report provides:An overview of the global market for...

2014-08-08 23:05:04

Biomarkers are substances produced by the body that can help assess disease risk. Boston, MA (PRWEB) August 08, 2014 Wouldn't it be wonderful if a single blood test could gauge the heart's health? Medicine isn't quite yet at that point. But there are a few indicators that can signal where your cardiovascular health is headed and let you know whether you need to take action now to prevent a heart attack or stroke, according to the August 2014 Harvard Women's Health Watch....

2014-08-01 16:23:54

Plasma RNA biomarker panel for colorectal cancer screening JERUSALEM, Aug. 1, 2014 /PRNewswire-iReach/ -- Bio-MarCare Technologies, a leader in the development of plasma RNA biomarkers for colorectal cancer (CRC), is offering for sale its proprietary Colon-MarCarePlex(TM) technology for the pre-cancerous polyps screening in blood. The purchaser will receive all intellectual property (IP) rights, know-how and current business relationships associated with MarCarePlex(TM) technology....


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.